Support- professional: other

Ended Awarded Last action

Contract number
HHSN268201200011I
Awardee
Awarding agency
Task orders
1 $713,046 obligated

Award facts

Combined order value
$713,046 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 7% used
$9,509,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Heart Lung and Blood Institute awarded an indefinite-delivery contract to Lonza Walkersville, Inc. on August 31, 2012, with a ceiling value of $9,509,000 and an ultimate completion date of September 16, 2017. This is a multiple-award IDIQ with no set-aside designation.

Work is performed at Lonza Walkersville's facility in Walkersville, Maryland. The contract supports NHLBI's research initiatives in cardiovascular and pulmonary science, procuring biological materials, cell culture media, specialized cell lines, and advanced scientific instrumentation including transfection systems and cell processing devices.

The period of performance runs through September 16, 2017. The NAICS classifications reflect the vendor's primary business in pharmaceutical preparation manufacturing, in-vitro diagnostic substance manufacturing, and analytical laboratory instrument manufacturing.

Task-order activity under this IDIQ included a delivery order awarded September 18, 2012, to Lonza Walkersville with a ceiling of $713,046 under the master vehicle titled "Gene Insertion - Pluripotent Stem Cells 2012-2017," supporting NHLBI's gene insertion and pluripotent stem cell research programs. The delivery order carried a firm fixed-price structure and no set-aside designation, with performance at the Walkersville, Maryland facility through the contract's completion date.

Task orders

Task order Ordering agency Obligated Awarded
Lonza walkersville, INC.:1110291 [12-006523] HHSN26800001 Office of the Director (NIH) $713,046

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 · Service $0
Original award $0

Quick answers

Who was awarded contract HHSN268201200011I?

HHSN268201200011I was awarded to Lonza Walkersville, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 31, 2012.

How much is contract HHSN268201200011I worth?

Orders under HHSN268201200011I have obligated $713,046. HHSN268201200011I's own ceiling is $9,509,000.

How many orders have been placed under contract HHSN268201200011I?

1 order has been placed under HHSN268201200011I, the latest on September 18, 2012.

Who can order from contract HHSN268201200011I?

HHSN268201200011I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN268201200011I part of a contract vehicle?

Yes. HHSN268201200011I is part of Gene Insertion - Pluripotent Stem Cells 2012-2017.

Was contract HHSN268201200011I competed?

The extent of competition for HHSN268201200011I was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV